Webinar Series:
Transplants – February 28, 2023
Leukemia – March 14, 2023
Cellular Therapies – March 22, 2023
Myeloma – April 12, 2023
Lymphoma – May 3, 2023

With several new drug and cellular therapies as well as an expansion of our understanding of the biologic heterogeneity of hematologic malignancies, there is a need for ongoing education in the area of hematologic malignancies. This interactive webinar series will focus on current best practices and major updates in the biology, diagnosis, and management of hematologic malignancies.

Each 90-minute webinar will have two talks followed by 30 minutes of discussion and audience questions. Presenters will include internationally-known disease experts from Mass General Cancer Center covering practice-changing updates in cellular therapies, transplant, myeloma, leukemia, and lymphoma.

Learning Objectives

Upon completion of this activity, participants will be able to:

  1. Identify new therapies available for hematologic malignancies.
  2. Discuss practice-changing updates in the management of hematologic malignancies.
  3. Discuss new concepts in palliative care and survivorship.
  4. Determine appropriate timing to consider transplant evaluation and cellular therapy referral for hematologic malignancies.

Target Audience

This activity is intended for physicians, nurses, physician assistants, other members of healthcare team (regional) with specialties such as general practice, hematology, hematology/oncology, medical oncology, primary care, and radiation oncology.

Course Director: